Stockreport

Cellino Appoints Chris Gemmiti, Ph.D., as SVP of Therapeutics Development [Yahoo! Finance]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF Gemmiti brings over 25 years of experience in cell therapy and regenerative medicine, having held leadership roles at CRISPR Therapeutics, Sentien, and Organogenesis Inc [Read more]